Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease.

Kasyan A, Medeiros LJ, Zuo Z, Santos FP, Ravandi-Kashani F, Miranda R, Vadhan-Raj S, Koeppen H, Bueso-Ramos CE.

Mod Pathol. 2010 Aug;23(8):1113-26. doi: 10.1038/modpathol.2010.96. Epub 2010 May 14.

2.

Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification.

Liu W, Hasserjian RP, Hu Y, Zhang L, Miranda RN, Medeiros LJ, Wang SA.

Mod Pathol. 2011 Mar;24(3):375-83. doi: 10.1038/modpathol.2010.194. Epub 2010 Nov 19.

3.

Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.

Bacher U, Haferlach C, Alpermann T, Kern W, Schnittger S, Haferlach T.

Haematologica. 2011 Sep;96(9):1284-92. doi: 10.3324/haematol.2011.043687. Epub 2011 May 23.

4.

Acute erythroid neoplastic proliferations. A biological study based on 62 patients.

Domingo-Claros A, Larriba I, Rozman M, Irriguible D, Vallespí T, Aventin A, Ayats R, Millá F, Solé F, Florensa L, Gallart M, Tuset E, Lopez C, Woessner S.

Haematologica. 2002 Feb;87(2):148-53. Review.

5.

Acute erythroid leukemia.

Zuo Z, Polski JM, Kasyan A, Medeiros LJ.

Arch Pathol Lab Med. 2010 Sep;134(9):1261-70. doi: 10.1043/2009-0350-RA.1. Review.

PMID:
20807044
6.

Clinicopathologic features and outcome of acute erythroid leukemia based on 2008 revised World Health Organization classification.

Liu CJ, Hong YC, Yang CF, Liu SH, Gau JP, Liu JH, Hsiao LT, Liu CY, Yu YB, Tzeng CH.

Leuk Lymphoma. 2012 Feb;53(2):289-94. doi: 10.3109/10428194.2011.607526. Epub 2011 Sep 23.

PMID:
21780998
7.

Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification.

Hasserjian RP, Zuo Z, Garcia C, Tang G, Kasyan A, Luthra R, Abruzzo LV, Kantarjian HM, Medeiros LJ, Wang SA.

Blood. 2010 Mar 11;115(10):1985-92. doi: 10.1182/blood-2009-09-243964. Epub 2009 Dec 29.

8.

Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases.

Kowal-Vern A, Mazzella FM, Cotelingam JD, Shrit MA, Rector JT, Schumacher HR.

Am J Hematol. 2000 Sep;65(1):5-13.

PMID:
10936857
9.

Erythroleukemia: a review of 15 cases meeting 1985 FAB criteria and survey of the literature.

Atkinson J, Hrisinko MA, Weil SC.

Blood Rev. 1992 Dec;6(4):204-14. Review.

PMID:
1486289
10.

Erythroleukemia: a need for a new definition.

Park S, Picard F, Dreyfus F.

Leukemia. 2002 Aug;16(8):1399-401. Review.

11.

Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes.

Senent L, Arenillas L, Luño E, Ruiz JC, Sanz G, Florensa L.

Haematologica. 2013 Apr;98(4):568-75. doi: 10.3324/haematol.2012.071449. Epub 2012 Oct 12.

12.

Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.

Morel P, Hebbar M, Lai JL, Duhamel A, Preudhomme C, Wattel E, Bauters F, Fenaux P.

Leukemia. 1993 Sep;7(9):1315-23.

PMID:
8371581
13.

Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification.

Wang SA, Tang G, Fadare O, Hao S, Raza A, Woda BA, Hasserjian RP.

Mod Pathol. 2008 Nov;21(11):1394-402. doi: 10.1038/modpathol.2008.142. Epub 2008 Sep 12.

14.

Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.

Rogers HJ, Vardiman JW, Anastasi J, Raca G, Savage NM, Cherry AM, Arber D, Moore E, Morrissette JJ, Bagg A, Liu YC, Mathew S, Orazi A, Lin P, Wang SA, Bueso-Ramos CE, Foucar K, Hasserjian RP, Tiu RV, Karafa M, Hsi ED.

Haematologica. 2014 May;99(5):821-9. doi: 10.3324/haematol.2013.096420. Epub 2014 Jan 24.

15.

Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes.

Calvo X, Arenillas L, Luño E, Senent L, Arnan M, Ramos F, Ardanaz MT, Pedro C, Tormo M, Montoro J, Díez-Campelo M, Arrizabalaga B, Xicoy B, Bonanad S, Jerez A, Nomdedeu B, Ferrer A, Sanz GF, Florensa L.

Mod Pathol. 2016 Dec;29(12):1541-1551. doi: 10.1038/modpathol.2016.146. Epub 2016 Aug 26.

PMID:
27562492
16.

Acute Erythroleukemias, Acute Megakaryoblastic Leukemias, and Reactive Mimics: A Guide to a Number of Perplexing Entities.

Wang SA, Hasserjian RP.

Am J Clin Pathol. 2015 Jul;144(1):44-60. doi: 10.1309/AJCPRKYAT6EZQHC7. Review.

PMID:
26071461
17.
18.

Acute myeloid leukaemia and myelodysplastic syndromes with 50% or greater erythroblasts: a diagnostic conundrum.

Wong E, Juneja S.

Pathology. 2015 Jun;47(4):289-93. doi: 10.1097/PAT.0000000000000244. Review.

PMID:
25938365
19.

Therapy-related myeloid neoplasms following treatment with radioiodine.

Schroeder T, Kuendgen A, Kayser S, Kröger N, Braulke F, Platzbecker U, Klärner V, Zohren F, Haase D, Stadler M, Schlenk R, Czibere AG, Bruns I, Fenk R, Gattermann N, Haas R, Kobbe G, Germing U.

Haematologica. 2012 Feb;97(2):206-12. doi: 10.3324/haematol.2011.049114. Epub 2011 Oct 11.

20.

Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes.

Solé F, Prieto F, Badia L, Woessner S, Florensa L, Caballin MR, Coll MD, Besses C, Sans-Sabrafen J.

Cancer Genet Cytogenet. 1992 Nov;64(1):12-20.

PMID:
1458444

Supplemental Content

Support Center